Graham P - Search Results

1

Cancer stem cells and signaling pathways in radioresistance.

Chang L, Graham P, Hao J, Ni J, Deng J, Bucci J, Malouf D, Gillatt D, Li Y. Chang L, et al. Among authors: graham p. Oncotarget. 2016 Mar 8;7(10):11002-17. doi: 10.18632/oncotarget.6760. Oncotarget. 2016. PMID: 26716904 Free PMC article. Review.

2

Targeted alpha therapy for cancer.

Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Zhang D, Song E, Qu CF, Kearsley J, Graham P, Thompson J. Allen BJ, et al. Among authors: graham p. Phys Med Biol. 2004 Aug 21;49(16):3703-12. doi: 10.1088/0031-9155/49/16/016. Phys Med Biol. 2004. PMID: 15446799

3

Intralesional targeted alpha therapy for metastatic melanoma.

Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Graham P, Thompson JF, Reisfeld RA, Kearsley J. Allen BJ, et al. Among authors: graham p. Cancer Biol Ther. 2005 Dec;4(12):1318-24. doi: 10.4161/cbt.4.12.2251. Epub 2005 Dec 18. Cancer Biol Ther. 2005. PMID: 16322682 Clinical Trial.

4

Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases.

Graham PH, Bucci J, Browne L. Graham PH, et al. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):648-54. doi: 10.1016/j.ijrobp.2009.05.032. Epub 2009 Oct 14. Int J Radiat Oncol Biol Phys. 2010. PMID: 19836153 Clinical Trial.

5

CD44 is a biomarker associated with human prostate cancer radiation sensitivity.

Xiao W, Graham PH, Power CA, Hao J, Kearsley JH, Li Y. Xiao W, et al. Clin Exp Metastasis. 2012 Jan;29(1):1-9. doi: 10.1007/s10585-011-9423-7. Epub 2011 Sep 28. Clin Exp Metastasis. 2012. PMID: 21953074

6

Role of the EpCAM (CD326) in prostate cancer metastasis and progression.

Ni J, Cozzi PJ, Duan W, Shigdar S, Graham PH, John KH, Li Y. Ni J, et al. Cancer Metastasis Rev. 2012 Dec;31(3-4):779-91. doi: 10.1007/s10555-012-9389-1. Cancer Metastasis Rev. 2012. PMID: 22718399 Review.

7

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y. Hao J, et al. PLoS One. 2012;7(8):e40716. doi: 10.1371/journal.pone.0040716. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22870202 Free PMC article.

8

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Chao H, Wang L, Hao J, Ni J, Chang L, Graham PH, Kearsley JH, Li Y. Chao H, et al. Cancer Lett. 2013 Feb 1;329(1):17-26. doi: 10.1016/j.canlet.2012.08.035. Epub 2012 Sep 18. Cancer Lett. 2013. PMID: 22995071

9

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Xiao W, Graham PH, Hao J, Chang L, Ni J, Power CA, Dong Q, Kearsley JH, Li Y. Xiao W, et al. PLoS One. 2013 Aug 26;8(8):e74253. doi: 10.1371/journal.pone.0074253. eCollection 2013. PLoS One. 2013. PMID: 23991216 Free PMC article.

10

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y. Ni J, et al. Among authors: graham p. Int J Biochem Cell Biol. 2013 Dec;45(12):2736-48. doi: 10.1016/j.biocel.2013.09.008. Epub 2013 Sep 25. Int J Biochem Cell Biol. 2013. PMID: 24076216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,116 results

Search Page